Selvita bridges Krakow and San Francisco

The company has officially opening its second office, which is dedicated to the support of the ongoing and future projects for business partners from the West Coast of US.

Selvita initiated its US operations in September 2015, opening a fully-owned US subsidiary, Selvita Inc., headquartered in Cambridge, MA. Now the company is officially opening its second office, which is dedicated to the support of the ongoing and future projects for business partners from the West Coast of US.

“The US drug discovery market is absolutely strategic for Selvita. It is not only where most of our revenue comes from, but also where we put most of our hopes in," said Pawel Przewiezlikowski, CEO at Selvita.

"We are continuously investing in top class-facilities and best professionals. In 2016 we are opening our second research facility in Poznan, Poland, and we believe we have even more to offer to our customers.

"The last several months of our operations on the US East Coast, have shown that our local presence is not only bringing us closer to our US clients, but also facilitating a more swift bidirectional transfer of know-how between our labs in Poland and the partner base in the US.

Having two US offices located in where the heart of the biotechnology industry beats — in Greater Boston and in the San Francisco Bay areas — is what will definitely bring us closer to achieving our goal of becoming the drug discovery partner of choice for the US biotech and pharma industry.”